Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pivotal Therapeutics Inc
PVTTF
Healthcare
Drug Manufacturers - Specialty & Generic
Pivotal Therapeutics Inc is a Canada based pharmaceutical company. It focuses on Omega-3 therapies for cardiovascular disease and overall health. The products of the company are VASCAZEN which is a prescription-only medical food for the treatment of an Omega-3 Deficiency in patients with cardiovascular disease, OMAZEN, and BENEFISHIAL which provides pure Omega-3 fatty acids for the maintenance...
of health. The firm operates in the United States and Canada of which majority of the revenue is derived from the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:PVTTF)
New Post
View:
Posts & Comments
Threaded Posts
(2)
•••
chance18
X
View Profile
View Bullboard History
Post by
chance18
on Aug 25, 2016 10:53pm
Are we toast.
You think the company would put something out .
(2)
•••
chance18
X
View Profile
View Bullboard History
Post by
chance18
on Jan 08, 2016 3:38pm
What's going on with this company.?
Do they have any customers or sales ?
(8)
•••
smithgee
X
View Profile
View Bullboard History
Post by
smithgee
on Jun 04, 2015 2:39pm
Pivotal enrolls first patient in Pomega phase IIa trial
Pivotal enrolls first patient in Pomega phase IIa trial 2015-06-04 14:31 ET - News Release Dr. George Jackowski reports FIRST PATIENT ENROLLED IN
...more
(0)
•••
Rosebud1964
X
View Profile
View Bullboard History
Comment by
Rosebud1964
on May 07, 2014 11:59am
RE:Pivotal Therapeutics announces issuance of U.S. Patent 8,715
EOM? Have you been following PVO for awhile...thoughts?
(8)
•••
smithgee
X
View Profile
View Bullboard History
Post by
smithgee
on May 07, 2014 11:49am
Pivotal Therapeutics announces issuance of U.S. Patent 8,715
eom
(33)
•••
picasso1
X
View Profile
View Bullboard History
Post by
picasso1
on Mar 14, 2014 11:20pm
Ton of money
These guys raised a ton of money recently. That got me curious. It looks like there is no market right now for this stock. They should consider spending some marketing dollars.
(0)
•••
1nvest0rs
X
View Profile
View Bullboard History
Post by
1nvest0rs
on Oct 04, 2013 3:05pm
News on Pivotal Therapeutics
Pivotal Therapeutics to raise $5 mln through debt financing, $2.7 mln equity raise completed
(0)
•••
1nvest0rs
X
View Profile
View Bullboard History
Post by
1nvest0rs
on Aug 29, 2013 3:33pm
News on Pivotal Therapeutics
Pivotal Therapeutics says Q2 sales grow 27% as Vascazen impresses cardiologists
(0)
•••
Rosebud1964
X
View Profile
View Bullboard History
Post by
Rosebud1964
on Jun 18, 2013 3:44pm
Its alive!
Next stop $5
(0)
•••
Rosebud1964
X
View Profile
View Bullboard History
Post by
Rosebud1964
on May 31, 2013 11:03am
good read
https://www.proactiveinvestors.com/companies/news/44454/omthera-acquisition-highlights-upside-potential-of-pivotal-therapeutics-44454.html
(0)
•••
Rosebud1964
X
View Profile
View Bullboard History
Post by
Rosebud1964
on May 30, 2013 7:26pm
$$$
$5 with in the year!!
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >